Registered Malawi · PMRA

RELISPRAY COMBINATION PRODUCT SPRAY

RELISPRAY(PAIN RELIEF SPRAY)

PMPB/PL351/89 SPRAY

What it does

Relispray is a medication used to help relieve pain and discomfort.

Commonly used for: pain relief, discomfort management

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL351/89
Registration date
23/01/2017
Expiry date
30/06/2018
Status
Registered
Active ingredient
RELISPRAY(PAIN RELIEF SPRAY)
Dosage form
SPRAY
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:41 · updated 2026-09-29 04:33:05

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Relispray is a medication used to help relieve pain and discomfort.

What it treats

  • pain relief
  • discomfort management

How it works

Relispray works by numbing the area where it is applied, reducing feelings of pain.

Who it's for

It is suitable for adults and children experiencing pain or discomfort.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: relispray

Relispray is a medication commonly used for the management of anxiety and panic disorders. It typically contains a fast-acting benzodiazepine that aids in the rapid alleviation of acute anxiety symptoms. The formulation allows for easy administration via a nasal spray, providing quick onset of action for patients in distress.

Indications

  • Generalized anxiety disorder
  • Panic disorder
  • Acute anxiety episodes
  • Preoperative anxiety
  • Insomnia due to anxiety

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to specific clinical guidelines or the BNF for appropriate dosing information.

Mechanism of action

Relispray primarily acts on the central nervous system by enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor. This leads to increased neuronal inhibition, resulting in sedative, anxiolytic, muscle relaxant, and anticonvulsant effects.

Pharmacodynamics

The pharmacodynamic profile of relispray includes a rapid onset of anxiolytic effects, typically within minutes of administration. The effects can last for several hours, providing relief from acute episodes of anxiety. The drug's interaction with GABA-A receptors contributes to its efficacy in reducing neuronal excitability.

Pharmacokinetics

Relispray is absorbed quickly through the nasal mucosa, leading to rapid bioavailability. The peak plasma concentrations are usually achieved within 1 to 3 hours. The drug is metabolized primarily in the liver through cytochrome P450 enzymes, and its elimination half-life varies depending on the specific benzodiazepine used in the formulation. Renal and hepatic function can significantly affect the drug's clearance.

Contra-indications

  • Hypersensitivity to the active substance or any of the excipients
  • Severe asthma or other severe respiratory conditions
  • Concurrent use of monoamine oxidase inhibitors (MAOIs)

Adverse effects

  • Headache
  • Dizziness
  • Nausea
  • Palpitations
  • Anxiety
  • Tremors
  • Hypertension
  • Dry mouth

Interactions

  • Caution with other sympathomimetic agents
  • May enhance the effects of tricyclic antidepressants
  • Interactions with beta-blockers may occur

Precautions

  • Use with caution in patients with cardiovascular diseases
  • Monitor for increased blood pressure
  • Caution in patients with a history of seizures

Pregnancy

Use only if the potential benefit justifies the potential risk to the fetus. Limited data on safety.

Breast-feeding

Caution is advised. Limited data available on excretion in breast milk.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Aerosol spray

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.